Bentham Science Logo

Track Your Manuscript:


Current Psychopharmacology

Volume 10, 3 Issues, 2021
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access

Most Accessed Articles




Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise

, 2021; 10(2): 123-137.

Bernard W. Downs*, Steve Kushner, Manashi Bagchi, Kenneth Blum, Rajendra D. Badgaiyan, Sanjoy Chakraborty and Debasis Bagchi


DOI: 10.2174/2211556010666210122145526


Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic

, 2021; 10(2): 86-97.

Kenneth Blum*, Edward J. Modestino, David Baron, Raymond Brewer, Panayotis Thanos, Igor Elman, Rajendra D. Badgaiyan, B. William Downs, Debasis Bagchi, Thomas McLaughlin, Abdalla Bowirrat, A. Kenison Roy and Mark S. Gold


DOI: 10.2174/2211556009999210104221215





Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth

, 2021; 10(1): 5-16.

Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*


DOI: 10.2174/2211556009999200613224100










Editor-in-Chief

Kenneth Blum
Department of Psychiatry
Western University of Health Sciences
Pomona, CA
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.

Advertisement

webinar-July-21

Related Journals

Related eBooks

eBooks Catalog